BRANDY BURT: Open Payments
NPI 1902575145 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 14 payments from 6 companies in 2025. Trend: 2023 $350 · 2024 $85 · 2025 $342
Food & beverage: $230Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $151 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Orexo US, Inc. | 1 | $14 |
Products named: Auvelity, CAPLYTA, AUSTEDO XR, COBENFY, INGREZZA, Zubsolv.
Industry payments across IN — which companies pay providers there.
